![](https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_200_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=hd_L3ztr 200w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_260_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=No5NaZFE 260w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_320_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=2gVFlHGa 320w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_400_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=F5D-C6Ru 400w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_520_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=c0BnjPa6 520w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_640_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=sNDvCGMs 640w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_800_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=0_B1tyTD 800w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_1040_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=C4ku0FhF 1040w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_1280_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=0H5LiM8H 1280w, https://www.anesthesiology.cuimc.columbia.edu/sites/default/files/styles/cola_media_1600_21_9/public/media/images/2020-01/0c6a2846_1.jpg?itok=ssAT-gRn 1600w)
Dr. Viola Neudecker Recognized As A Leader In Her Field
January 29, 2020
Dr. Viola Neudecker was recognized for her work at the 2019 annual meetings of three leading field organizations, the International Anesthesia Research Society (IARS), the Society for Neuroscience in Anesthesiology and Critical Care (SNACC), and the American Society of Anesthesiologists (ASA). Dr. Neudecker joined Dr. Brambrink’s lab in 2018 as a physician-scientist researching developmental neurotoxicity. She works closely with Dr. Jose Perez-Zoghbi here at CUMC and with Dr. Brambrink’s former research team at Oregon Health Sciences University.
- At the annual meeting of the IARS, Dr. Neudecker received the Kosaka Best of Meeting Award for “GFAP expression in the visual cortex is increased in juvenile non-human primates that were exposed to anesthesia during infancy.” Her work on infant anesthesia neurotoxicity is highlighted by the IARS in this interview on the society’s website.
- At SNACC’s annual meeting, Dr. Neudecker was presented with the Best of Meeting Award in the Basic Neuroscience Category and with the Abstract Award from Women in Neuroanesthesiology and Neuroscience Education and Research (WINNER) for “Infant Isoflurane Exposure Affects Social Behaviors but not Cognitive Functions in Juvenile Non-Human Primates.” SNACC created WINNER in 2018 to help balance gender equity in academic neuroanesthesia by rewarding excellence in research contributions by women. An interview with Dr. Neudecker is featured in the current SNACC newsletter.
- At the annual meeting of the ASA, “Infant Isoflurane Exposure Affects Social Behaviors but not Cognitive Functions in Juvenile Non-Human Primates” was selected for oral presentation in the “Best Abstracts” session.
Our heartiest congratulations to Dr. Neudecker for a productive and successful year!